Searched for
CLARIS LIFESCIENCES SHARES
FIIs/FPIs restricted from buying more shares in Fortis, ClarisFIIs, NRIs and PIOs (Persons of Indian Origins) can invest in primary and secondary capital markets in India through Portfolio Investment S...- Claris Life gets USFDA nod for generic anesthetic injectionThe injection is indicated for the production of local or regional anesthesia or analgesia for surgery, diagnostic and therapeutic procedur...
- Claris Lifesciences revives talks to sell injectables businessSources suggest that it has evinced interest amongst pharma companies like Cadila Healthcare, Dr Reddy’s Labs, Torrent Pharma amongst other...
- Claris Lifesciences gets nod to resume supply of Furosemide injection in USClaris Lifesciences said it has received prior approval supplement (PAS) for Furosemide injection which will help it to resume supply in th...
- Claris Life surges over 10% on buzz of injectable business saleStocks of Claris Lifesciences surged over 10% today amid reports that Cadila Healthcare has emerged as the front runner to acquire the gene...
- Carlyle Group sells its entire 11.29% stake in Claris LifesciencesCarlyle Group offloaded its entire 11.29 per cent stake in drug-maker Claris Lifesciences for a little over Rs 170 crore through an open ma...
- Claris Lifesciences Q4 net zooms five-fold at Rs 90 croreClaris Lifesciences reported an over five-fold jump in its consolidated net profit at Rs 89.84 crore for the quarter ended December 31, 210...
- Claris confirms patent challenge for generic Propofol in USThe company has filed a an ANDA for Propofol injection in strength of 10 mg/ml with the US Food and Drug Administration (FDA).
- Claris Lifesciences shares up 3.5 per cent on BSEStock of Claris Life ended the day 3.56 per cent higher at Rs 181.60 on the BSE. In intra-day, it gained 6.33 per cent to Rs 186.45.
- Claris Lifesciences gets Medicines and Healthcare products Regulatory Agency's nod for new plant"This is the first regulatory inspection and compliance approval conducted by MHRA-UK in line with the EU GMP regulations for plant 2."
- Claris Lifesciences gets FIPB nod for Japanese JV, Q1 net down by 29%Ahmedabad-based Claris Lifesciences registered de-growth of 29% in its first quarter ended on 31st March 2013.
- Claris promoter sells 12 lakh shares for over Rs 23 croreClaris Lifesciences promoter Aditya Sushil Kumar Handa today offloaded nearly 12 lakh shares of the pharma company for over Rs 23 crore.
- Claris Lifesciences in talks with Otsuka Pharma to sell injectables business: SourcesShares of Claris have rallied 165 per cent from the start of the year and are currently trading at their lifetime high.
- Buy Claris Lifescience with a price target of Rs 280: Prakash GabaBuy Claris Lifescience with a price target of Rs 280 and a stop loss of Rs 240.
- Claris Lifesciences promoter sells 10 lakh sharesAditya Sushil Kumar Handa, one of the promoters of Claris Lifesciences, today sold 10 lakh shares of the drug company.
- Claris Lifesciences net profit falls 14%, USFDA clearance awaitingThe consolidated net profit stood at Rs 32.32 crore for second quarter ended on 30 June 2012 compared to Rs 37.72 crore for the same period...
- Claris Lifesciences promoter offloads over 17 lakh sharesAditya Sushil Kumar Handa, one of the promoters of Claris Lifesciences, today sold over 17.33 lakh shares of the drug company for Rs 28 cro...
- Citi offloads over 3 lakh shares of Claris LifesciencesForeign fund house Citigroup sold 3.19 lakh shares, worth about Rs 5 crore, of drug-maker Claris Lifesciences through an open market transa...
- USFDA to inspect facilities of Zydus, Claris Lifesciences for violating American drug manufacturing normsFDA had issued warning letter for Cadila's injectable unit at its plant in July for not meeting US drug manufacturing norms .
- Carlyle likely to dilute stake in Claris LifeTop private equity firm Carlyle Group is likely to partially exit Claris Lifesciences Ltd, the Rs 800-crore Ahmedabad based parenteral drug...
Load More
